DEFA14A: Merit Medical Systems, Inc. Sets Date for 2025 Annual Meeting, Outlines Voting Proposals

Sentiment:

Proxy Statement


Merit Medical Systems, Inc. announces its 2025 Annual Meeting of Shareholders to be held virtually on May 14, 2025, with key proposals including the election of directors and ratification of the company's executive compensation and auditor appointment.

Summary

  • Merit Medical Systems, Inc. will hold its Annual Meeting on May 14, 2025, at 2:00 PM MDT, conducted virtually.
  • Shareholders can vote on the election of four directors for a three-year term: Thomas J. Gunderson, Laura S. Kaiser, Michael R. McDonnell, and F. Ann Millner, Ed.D.
  • A non-binding advisory resolution to approve the compensation of the company's named executive officers will be voted on.
  • The ratification of Deloitte & Touche LLP as the independent registered public accounting firm for the year ending December 31, 2025, is also up for vote.
  • Shareholders can access meeting materials and vote online at www.ProxyVote.com or request copies by April 30, 2025.
  • For shares held in the Merit Medical Systems, Inc. 401(k) Profit Sharing Plan, vote by May 9, 2025 11:59 PM ET.
  • The deadline to vote is May 13, 2025 11:59 PM ET.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, indicating a neutral to slightly positive sentiment as it reflects the company's adherence to corporate governance practices.

Positives

  • The virtual format of the Annual Meeting allows for broader shareholder participation.
  • Shareholders have multiple options for accessing meeting materials and voting, including online and by requesting physical copies.

Future Outlook

The document outlines the standard procedures for an upcoming annual meeting, with no specific forward-looking financial statements or guidance provided.

Industry Context

This announcement is a routine part of corporate governance, ensuring shareholders have the opportunity to vote on key company matters. It aligns with standard practices for publicly traded companies.

Stakeholder Impact

  • Shareholders have the opportunity to influence the company's direction through voting.
  • The outcome of the votes will impact the composition of the Board of Directors and the selection of the company's auditor.

Next Steps

  • Shareholders should review the proxy materials and vote on the proposals by the specified deadline.
  • The company will proceed with the Annual Meeting on May 14, 2025.

Key Dates

DateDescription
April 30, 2025Deadline to request a copy of the proxy materials.
May 9, 2025Voting deadline for shares held in the Merit Medical Systems, Inc. 401(k) Profit Sharing Plan.
May 13, 2025Voting deadline.
May 14, 2025Annual Meeting date.
December 31, 2025Year-end for which Deloitte & Touche LLP will serve as the independent registered public accounting firm.

Keywords

Annual Meeting, Proxy Statement, Shareholders, Voting, Directors, Executive Compensation, Auditor, Deloitte & Touche, Merit Medical Systems

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.